Last week, Celsius Therapeutics announced an additional $83M USD in financing and we are excited to be a part of this syndicate. Amplitude decided to support the company to advance its lead… Read More
Izotropic Corporation (OTCQB: IZOZF | CSE: IZO) is just gaining the attention of Wall Street, as production plans ramp up. In a sign that women’s health may be about to see the biggest… Read More
A project at Providence Health Care aims to take the hospital food tray and turn it into a platform for culturally appropriate care for Indigenous patients. The objective of the… Read More
Efficacy and safety data from the Effisayil™ 1 trial presented at AAD 2022 showed rapid pustular and skin clearance was sustained over 12 weeks in patients with GPP flares treated with… Read More
Xenpozyme® (olipudase alfa) approved in Japan, first and only approved therapy indicated to treat acid sphingomyelinase deficiency Xenpozyme represents first Sanofi therapy to be approved under the SAKIGAKE ‘fast-track’ designation Approval based on positive results… Read More
